Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.

被引：0
|
作者：
Maraka, Stefania
Groves, Morris D.
Mammoser, Aaron Gerald
Melguizo-Gavilanes, Isaac
Conrad, Charles A.
Tremont-Lukats, Ivo
Loghin, Monica Elena
O'Brien, Barbara Jane
Puduvalli, Vinay K.
Sulman, Erik P.
Hess, Kenneth R.
Aldape, Kenneth D.
Gilbert, Mark R.
De Groot, John Frederick
Yung, W. K. Alfred
Penas-Prado, Marta
机构：
[1] Univ Texas MD Anderson Canc Ctr, Neurooncol Dept, Houston, TX USA
[2] LSU Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA USA
[3] Aurora Canc Care Neurooncol, Milwaukee, WI USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Houston Methodist Hosp, Neurooncol, Neurol, Houston, TX USA
[6] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[7] Natl Canc Inst, Ctr Canc Res, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2044
引用
收藏
页数：1
相关论文
共 50 条
  • [11] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Patel, Neha
    Khosla, Atulya
    Rauf, Yasmeen
    Stevens, Glen
    Murphy, Erin
    Chao, Samuel
    Yu, Jennifer
    Suh, John
    Peereboom, David
    NEURO-ONCOLOGY, 2022, 24 : 60 - 60
  • [12] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Rauf, Yasmeen
    Peereboom, David
    Fallah, Jaleh
    Schilero, Cathy
    Lackner, Pamela
    Stevens, Glen
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 37 - 37
  • [13] Phase I lead-in to a 2x2x2 factorial trial of dose-dense temozolomide, memantine, mefloquine, and metformin as postradiation adjuvant therapy of glioblastoma (GBM).
    Penas-Prado, Marta
    Groves, Morris D.
    Mammoser, Aaron A.
    Melguizo, Isaac
    De Groot, John Frederick
    Conrad, Charles A.
    Tremont-Lukats, Ivo
    Loghin, Monica Elena
    Puduvalli, Vinay K.
    Sulman, Erik P.
    Hess, Kenneth R.
    Aldape, Kenneth D.
    Gilbert, Mark R.
    Yung, W. K. Alfred
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [14] RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
    Chinnaiyan, Prakash
    Won, Minhee
    Wen, Patrick Y.
    Rojiani, Amyn
    Wendland, Merideth M.
    DiPetrillo, Thomas A.
    Corn, Benjamin W.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [15] Comparative study of six cycles versus twelve cycles of adjuvant temozolomide post concurrent chemoradiation in newly diagnosed glioblastoma.
    Bhandari, Menal
    Gandhi, Ajeet K.
    Julka, Pramod Kumar
    Sarkar, Chitra
    Sharma, Dayanand
    Rath, Goura Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [16] Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    Page, Margaretta
    Rabbitt, Jane
    Federoff, Anne
    Parvataneni, Rupa
    Nicol, Steven
    Musib, Luna
    Liepa, Astra
    Thornton, Donald
    Prados, Michael
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3345S - 3345S
  • [17] Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
    Chang, SM
    Lamborn, KR
    Malec, M
    Larson, D
    Wara, W
    Sneed, P
    Rabbitt, J
    Page, M
    Nicholas, MK
    Prados, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 353 - 357
  • [18] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
  • [19] A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
    Rosenfeld, Myrna R.
    Ye, Xiaobu
    Supko, Jeffrey G.
    Desideri, Serena
    Grossman, Stuart A.
    Brem, Steven
    Mikkelson, Tom
    Wang, Daniel
    Chang, Yunyoung C.
    Hu, Janice
    McAfee, Quentin
    Fisher, Joy
    Troxel, Andrea
    Piao, Shengfu
    Heitjan, Daniel F.
    Tan, Kay See
    Pontiggia, Laura
    O'Dwyer, Peter J.
    Davis, Lisa E.
    Amaravadi, Ravi K.
    AUTOPHAGY, 2014, 10 (08) : 1359 - 1368
  • [20] RANDOMIZED PHASE II TRIAL OF TUMOR TREATING FIELDS PLUS RADIATION THERAPY PLUS TEMOZOLOMIDE COMPARED TO RADIATION THERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Limon, D.
    Bokstein, F.
    Blumenthal, D.
    Ben Harush, C.
    Ram, Z.
    Grossman, R.
    NEURO-ONCOLOGY, 2019, 21 : 86 - 86
12345